Sustainability
Environmental Initiatives
- Environmental Policy
- Efforts to Reduce Greenhouse Gas Emissions
- Promoting Environmental Management
- Biodiversity and Reduction of Waste
Environmental Policy
We fulfill our social mission of providing a stable supply of pharmaceuticals and recognize the significant impact that our business activities have on the global environment and biodiversity. In all aspects of our business activities, we strive to harmonize with the environment and actively work to reduce and conserve environmental impact. Through these efforts, we strive to continuously review and improve our targets, thereby contributing to the realization of a sustainable society.
Basic Policy
-
Reduction of environmental impact
- We will work to reduce greenhouse gas emissions by improving delivery efficiency and promoting conversion to environmentally friendly vehicles.
- We will strive to reduce energy consumption, water consumption, and waste emissions in our business activities and promote the effective use of resources.
-
Proactive introduction of environmentally friendly technologies
- We actively investigate new technologies and methods that contribute to reducing environmental impact and promote their introduction into our business activities.
-
Compliance with environmental laws and regulations
- We will comply with global environmental regulations, ordinances and other requirements to which we agree.
-
Improvement and penetration of environmental awareness
- We will make this Environmental Policy known to all employees.
- In order to raise awareness of environmental conservation, we will carry out education and enlightenment activities on an ongoing basis and encourage each and every employee to actively participate in environmental activities.
-
Disclosure and communication of environmental information
- We will actively disclose this Environmental Policy and our environmental initiatives and data through websites and other means to ensure transparency.
- We will actively communicate with local communities and all stakeholders by participating in environmental activities in local communities.
- We will promote cooperation and activities to reduce environmental impact throughout the supply chain.
Efforts to Reduce Greenhouse Gas Emissions
Introduction of Renewable Energy
Solar power generation installations
The Group has installed solar power systems at TOHO PHARMACEUTICAL’s Yamanashi Sales Department, the Kensei Sales Office (Kanagawa), and the Tokatsu-Kita Sales Office (Chiba). Moving forward, the Group plans to proactively introduce these systems at all newly established facilities.
Switching to renewable energy plans
Since December 2023, the Group has been gradually switching from fossil fuel electricity to renewable energy. Going forward, the Group will continue to introduce this system, mainly at distribution centers, which use large amounts of electricity.
Developing eco-friendly facilities
At newly established sales offices within the pharmaceutical wholesaling business, the Group is actively promoting the introduction of equipment designed to reduce environmental impact. For instance, the Kensei Sales Office (Kanagawa), newly built in FY2024, is equipped with solar power systems and has achieved a 6-star rating—the highest evaluation possible— under the Building-housing Energy-efficiency Labeling System (BELS). Furthermore, at its existing locations, the Group strives to minimize its environmental impact by installing solar panels to generate energy, converting buildings into Net Zero Energy Buildings (ZEBs), and setting up EV charging stations.
Delivery- and Vehicle-Related Initiatives
Promoting higher delivery efficiency
By introducing a scheduled delivery system and a delivery management system, the Group is working to improve delivery efficiency with the aim of reducing mileage by 30% by FY2030. The Group is also promoting scheduled deliveries based on automatic ordering through the centralized administration system for pharmacy operations “MIZAR,” which enables it to deliver one to two times a week for some of our regular customers.
Transitioning to electric vehicles (EVs)
The Group is actively transitioning from gasoline-powered vehicles to electric vehicles (EVs) and other eco-friendly alternatives, while also expanding the installation of EV charging stations.
Energy Management at Logistics Centers
Introduction of BEMS (Building Energy Management System)
Logistics centers have many air conditioners and a lot of lighting equipment and use large material handling equipment and robots. This results in higher electricity consumption than other business offices. For this reason, the Group has introduced BEMS at its Logistics centers to manage the consumption.
Utilization of night-time electricity and regenerative energy
The robots at TBC DynaBASE are operated also by utilizing off-peak electricity, and the head part, where the robot vacuums products, is a power-saving type that stops vacuuming when a certain amount of power is generated. The automatic warehouse is a regenerative energy type that is charged when the conveyor brakes. The system is also used at TBC Saitama and TBC Hiroshima.
Promoting Environmental Management
Achieving ISO14001 certification
The manufacturing facility of KYOSOMIRAI PHARMA has acquired ISO 14001:2015 certification, an international standard for environmental management systems, in order to continuously improve activities of energy conservation and waste reduction.
Biodiversity and Reduction of Waste
Basic Views
Pharmaceutical wholesaling, the Group’s core business, mainly distributes and sells pharmaceuticals. It has no direct impact on the natural environment through the collection and production of raw materials, and the risk of using chemical substances that adversely affect biodiversity and the discharge of waste is considered relatively low. However, the Group recognizes that it is important to accurately understand how its business depends on and affects the natural environment. In addition, sustainable resource procurement is needed throughout the supply chain, including production and logistics processes, and collaboration with suppliers and environmentally conscious decision-making must be strengthened. Therefore, the Group has positioned the conservation and restoration of biodiversity and the reduction of waste as a priority issue and is promoting initiatives to address it.
Initiatives for Waste Reduction
Reducing pharmaceutical product waste
If a manufacturing and sales business operator violates GMP (Good Manufacturing Practices), it must recall and dispose of the drug in question. At KYOSOMIRAI PHARMA, its major proposition is compliance with Good Manufacturing Practice (GMP). On this basis, KYOSOMIRAI PHARMA forecasts market demand in cooperation with the Group's wholesale and dispensing pharmacy businesses so as not to generate waste products caused by excess production.





